Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 389 Records) |
| Query Trace: CYP3A[original query] |
|---|
| Regulatory variants in a novel distal enhancer regulate the expression of CYP3A4 and CYP3A5. Clinical and translational science 2022 Aug . Collins Joseph M, Nworu Adaeze C, Mohammad Somayya J, Li Liang, Li Chengcheng, Li Chuanjiang, Schwendeman Ethan, Cefalu Mattew, Abdel-Rasoul Mahmoud, Sun Jessie W, Smith Sakima A, Wang Danx |
| Investigation of pharmacologic interactions between omeprazole and tacrolimus in a membranous nephropathy patient with CYP3A5 nonexpresser: a case report. Pharmacogenetics and genomics 2022 8 32 (7): 268-271. Li Yanli, Liu Yi, Sun Zengxi |
| CYP3A and CYP2B6 Genotype Predicts Glucose Metabolism Disorder among HIV Patients on Long-Term Efavirenz-Based ART: A Case-Control Study. Journal of personalized medicine 2022 Jun 12 (7): . Tadesse Wondmagegn Tamiru, Mlugu Eulambius Mathias, Shibeshi Workineh, Degu Wondwossen Amogne, Engidawork Ephrem, Aklillu Ele |
| Donor CYP3A5 Expression Decreases Renal Transplantation Outcomes in White Renal Transplant Recipients. Annals of transplantation 2022 Jul 27 e936276. Warzyszy?ska Karola, Zawistowski Micha?, Karpeta Edyta, Ja?brzykowska Agnieszka, Kosieradzki Maci |
| Tacrolimus CYP3A Single-Nucleotide Polymorphisms and Preformed T- and B-Cell Alloimmune Memory Improve Current Pretransplant Rejection-Risk Stratification in Kidney Transplantation. Frontiers in immunology 2022 13 869554. Crespo Elena, Vidal-Alabró Anna, Jouve Thomas, Fontova Pere, Stein Maik, Mocka Sonila, Meneghini Maria, Sefrin Anett, Hruba Petra, Gomà Montserrat, Torija Alba, Donadeu Laura, Favà Alex, Cruzado Josep M, Melilli Edoardo, Moreso Francesc, Viklicky Ondrej, Bemelman Frederike, Reinke Petra, Grinyó Josep, Lloberas Nuria, Bestard Ori |
| Correlation of 1846G>A Polymorphism of CYP2D6 Gene with Haloperidol Efficacy and Safety in Patients with Alcoholic Hallucinoses. Psychopharmacology bulletin 2022 06 52 (3): 58-67. Parkhomenko A A, Zastrozhin M S, Skryabin VYu, Ivanchenko V A, Pozdniakov S A, Noskov V V, Zaytsev I A, Denisenko N P, Akmalova K A, Bryun E A, Sychev D |
| Development of Physiology Based Pharmacokinetic Model to Predict the Drug Interactions of Voriconazole and Venetoclax. Pharmaceutical research 2022 Jun . Dong Ji, Liu Shuai-Bing, Rasheduzzaman Jony Md, Huang Chen-Rong, Miao Li-Y |
| Single-nucleotide polymorphisms and the effectiveness of taxane-based chemotherapy in premenopausal breast cancer: a population-based cohort study in Denmark. Breast cancer research and treatment 2022 Apr . Hjorth Cathrine F, Damkier Per, Stage Tore B, Feddersen Søren, Hamilton-Dutoit Stephen, Rørth Mikael, Ejlertsen Bent, Lash Timothy L, Ahern Thomas P, Sørensen Henrik T, Cronin-Fenton Deird |
| Drug-Drug Interactions and Disease Status Are Associated With Irinotecan-Induced Hepatotoxicity: A Cross-Sectional Study in Shanghai. Journal of clinical pharmacology 2022 4 62 (9): 1160-1169. Li Juan, Chen Bing, Xi Wen-Qi, Jia Wan, Zhang Wei-Xia, Bian Xiao-L |
| CYP3A4*22 and CYP3A5*3 impact efficacy and safety of diazepam in patients with alcohol withdrawal syndrome. Nordic journal of psychiatry 2022 4 77 (1): 73-76. Skryabin Valentin Yurievich, Franck Johan, Lauschke Volker Martin, Zastrozhin Mikhail Sergeevich, Shipitsyn Valery Valerievich, Bryun Evgeny Alekseevich, Sychev Dmitry Alekseevi |
| Effects of tacrolimus intrapatient variability and CYP3A5 polymorphism on the outcomes of pediatric kidney transplantation. Pediatric transplantation 2022 4 26 (6): e14297. Choi Jin Sun, Ko Hyunmin, Kim Hyo Kee, Chung Chris, Han Ahram, Min Seung-Kee, Ha Jongwon, Kang Hee Gyung, Ha Il Soo, Min Sang |
| Impact of the Genotype and Phenotype of CYP3A and P-gp on the Apixaban and Rivaroxaban Exposure in a Real-World Setting. Journal of personalized medicine 2022 4 12 (4): . Lenoir Camille, Terrier Jean, Gloor Yvonne, Gosselin Pauline, Daali Youssef, Combescure Christophe, Desmeules Jules Alexandre, Samer Caroline Flora, Reny Jean-Luc, Rollason Victor |
| Pregnancy Increases CYP3A Enzymes Activity as Measured by the 4?-Hydroxycholesterol/Cholesterol Ratio. International journal of molecular sciences 2022 12 23 (23): . Mlugu Eulambius M, Minzi Omary M, Kamuhabwa Appolinary A R, Diczfalusy Ulf, Aklillu Ele |
| Evaluation of effects of indoxyl sulfate and parathyroid hormone on CYP3A activity considering the influence of CYP3A5 gene polymorphisms. British journal of clinical pharmacology 2023 7 . Ayako Oda, Yosuke Suzuki, Chisato Yoshijima, Haruki Sato, Ryota Tanaka, Hiroyuki Ono, Ryosuke Tatsuta, Tadasuke Ando, Toshitaka Shin, Hiroki Itoh, Keiko Oh |
| Composite CYP3A (CYP3A4 and CYP3A5) phenotypes and influences on tacrolimus dose adjusted concentration in adult heart transplant recipients. Research square 2023 6 . Savine Hernandez, Christina Aquilante, Kimberly Deininger, Joann Lindenfeld, Kelly Schlendorf, Sara Van Driest, Michelle L |
| Pharmacogenetic interactions of efavirenz or rifampin and isoniazid with levonorgestrel emergency contraception during treatment of HIV or tuberculosis. Pharmacogenetics and genomics 2023 6 . Nana Agyemang, Kimberly K Scarsi, Paxton Baker, Laura M Smeaton, Anthony T Podany, Maxine Olefsky, Elizabeth Woolley, Elizabeth Barr, Michelle Pham, Sajeeda Mawlana, Khuanchai Supparatpinyo, Sivaporn Gatechompol, Emilia M Jalil, Luis Gadama, Sharlaa Badal-Faesen, Marije Van Schalkwyk, Cecelia Kayama, Pablo F Belaunzaran-Zamudio, Catherine Godfrey, Susan E Cohn, Rosie Mngqibisa, David W Haas, |
| High hepatic and plasma exposures of atorvastatin in subjects harboring impaired cytochrome P450 3A4?16 modeled after virtual administrations and possibly associated with statin intolerance found in the Japanese adverse drug event report database. Drug metabolism and pharmacokinetics 2023 2 49 100486. Adachi Koichiro, Ohyama Katsuhiro, Tanaka Yoichi, Sato Tasuku, Murayama Norie, Shimizu Makiko, Saito Yoshiro, Yamazaki Hiros |
| [Study of allelic variants of the CYP2D6 and CYP3A genes on the effectiveness and safety of tamsulosin therapy in patients with BPH: results of a pilot study]. Urologiia (Moscow, Russia : 1999) 2023 12 (6): 5-13. P Abdullaev Sh, N Shatokhin M, N Tuchkova S, P Abdullaev Sh, V Teodorovich O, B Loran O, A Sychev |
| The impact of CYP3A4 and CYP3A5 genetic variations on tacrolimus treatment of living-donor Egyptian kidney transplanted patients. Journal of clinical laboratory analysis 2023 10 e24969. Hanaa Wanas, Mai Hamed Kamel, Emad Adel William, Tarek Fayad, Mohamed Essmat Abdelfattah, Hossein Mostafa Elbadawy, Emily Samir Mikha |
| Is higher docetaxel clearance in prostate cancer patients explained by higher CYP3A: An in vivo phenotyping study with midazolam. Journal of clinical pharmacology 2023 10 . Lisa T van der Heijden, Claire A Ribbers, M A C Vermunt, D Pluim, M Acda, M Tibben, H Rosing, J A J Douma, K Naipal, A M Bergman, J H Beijnen, A D R Huitema, F L Opd |
| Genetic Susceptibility to Neurotoxicity Related to Prenatal Inorganic Arsenic Exposure in Young Spanish Children. Environmental science & technology 2023 10 . Raquel Soler-Blasco, Sabrina Llop, Gabriel Riutort-Mayol, Manuel Lozano, Jorge Vallejo-Ortega, Mario Murcia, Ferran Ballester, Amaia Irizar, Ainara Andiarena, Nora Fernandez-Jimenez, Simone Braeuer, Florencia Hara |
| Effect of Isotretinoin on CYP2D6 and CYP3A Activity in Patients with Severe Acne. British journal of clinical pharmacology 2023 10 . Yuqian Zhao, Jay C Vary, Aprajita S Yadav, Lindsay C Czuba, Sara Shum, Jeffrey LaFrance, Weize Huang, Nina Isoherranen, Mary F Hebe |
| Impact of Posaconazole and Diltiazem on Pharmacokinetics of Encorafenib, a BRAF V600 Kinase Inhibitor for Melanoma and Colorectal Cancer with BRAF Mutations. Clinical and translational science 2023 10 . Erik Hahn, Renae Chavira, Lance Wollenberg, Weiwei Tan, Micaela B Red |
| CYP3A5 Expressor Genotype of the Transplanted Kidney Increases the Risk of Preterm Graft Loss and Acute Rejection. Nephron 2023 1 1-9. Warzyszy?ska Karola, Zawistowski Micha?, Karpeta Edyta, Ja?brzykowska Agnieszka, Kosieradzki Maci |
| Exploring pharmacokinetic variability of palbociclib in HR+/HER2- metastatic breast cancer: a focus on age, renal function, and drug-gene interactions. Frontiers in pharmacology 2024 9 15 1420174. Elena Peruzzi, Bianca Posocco, Lorenzo Gerratana, Margherita Nuti, Marco Orleni, Sara Gagno, Elena De Mattia, Fabio Puglisi, Erika Cecchin, Giuseppe Toffoli, Rossana Ronca |
| Pharmacogenetic analysis of interleukin-10 variants and tacrolimus metabolism in kidney transplant patients from Pakistani population. Molecular biology reports 2024 8 51 (1): 947. Tuba Batool, Fareeha Ahmad, Rasheeda Bashir, Sana Rafaq |
| Steroid-tacrolimus drug-drug interaction and the effect of CYP3A genotypes. British journal of clinical pharmacology 2024 7 . Abdelrahman Saqr, Mahmoud Al-Kofahi, Moataz Mohamed, Casey Dorr, Rory P Remmel, Guillaume Onyeaghala, William S Oetting, Weihua Guan, Roslyn B Mannon, Arthur J Matas, Ajay Israni, Pamala A Jacobs |
| Single Nucleotide Polymorphisms of CYP3A4 and CYP3A5 in Romanian Kidney Transplant Recipients: Effect on Tacrolimus Pharmacokinetics in a Single-Center Experience. Journal of clinical medicine 2024 4 13 (7): . Corina Andreea Rotarescu, Ion Maruntelu, Ion Rotarescu, Alexandra-Elena Constantinescu, Ileana Constantines |
| Tools for a personalized tacrolimus dose adjustment in the follow-up of renal transplant recipients. Metabolizing phenotype according to CYP3A genetic polymorphisms versus concentration-dose ratio. Nefrologia 2024 4 . Anna Vidal-Alabró, Helena Colom, Pere Fontova, Gema Cerezo, Edoardo Melilli, Nuria Montero, Ana Coloma, Anna Manonelles, Alex Favà, Josep M Cruzado, Joan Torras, Josep M Grinyó, Nuria Llober |
| Characterization of plasma vonoprazan and CYP3A activity using its endogenous marker and genetic variants in patients with digestive system disorders. Drug metabolism and pharmacokinetics 2024 10 101027. Kenta Sakaguchi, Takafumi Naito, Kohei Hoshikawa, Yukari Miyadera, Hironari Tanaka, Emi Nakatsugawa, Takahisa Furuta, Ken Sugimoto, Junichi Kawaka |
- Page last reviewed:Feb 1, 2024
- Content source: